Phase II trial of inhaled apomorphine in patients with idiopathic Parkinson's disease.
Phase of Trial: Phase II
Latest Information Update: 05 Nov 2010
At a glance
- Drugs Apomorphine (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors Vectura
- 05 Nov 2010 New trial record.